Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Colonization resistance is a property of the host’s indigenous microbiota, notably in the gut, that protects against invasion and expansion of pathogenic microorganisms. The phenomenon involves both direct competitive interactions (e.g. nutrient competition, production of inhibitory substances such as bacteriocins) and indirect effects (such as stimulating host immune responses). Disruption of colonization resistance—especially due to antibiotics, illness, or altered diet—can increase susceptibility to opportunistic and drug-resistant infections. It is an emergent property of complex microbial communities and is not attributable to a single receptor, molecule, or target.
Antibiotics: Disrupt normal microbiota, reducing colonization resistance and increasing susceptibility to infection; Probiotics/Transplantation: Restore or enhance microbiome functionality to confer colonization resistance
2 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Colonization resistance.